<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161433">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01886495</url>
  </required_header>
  <id_info>
    <org_study_id>high protein diet in children</org_study_id>
    <nct_id>NCT01886495</nct_id>
  </id_info>
  <brief_title>Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children</brief_title>
  <official_title>High Protein Diet , Adiponectin and Inflammatory Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isfahan University of Medical Sciences</source>
  <oversight_info>
    <authority>Iran: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aimed to determine the effects of HP diet on adiponectin and inflammatory
      factors among overweight and obese children.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>adiponectin (mcg/ml)</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>amount of adiponectin</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>interlukine 6 (mcg/ml)</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tumor necrosis factor alpha (ng/ml)</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C reactive protein (mcg/ml)</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fibrinogen (mcg/ml)</measure>
    <time_frame>10 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Body Mass Index Quantitative Trait Locus 5 Disorder</condition>
  <condition>Tangier Disease</condition>
  <arm_group>
    <arm_group_label>nutrition intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>high protein diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control diet</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nutrition intervention</intervention_name>
    <arm_group_label>nutrition intervention</arm_group_label>
    <other_name>high protein diet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 85th

          -  age of 6-11 years

          -  no history of chronic diseases

          -  taken medications

        Exclusion Criteria:

          -  do not prescribe their diet

          -  mental retardation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leila Azadbakht, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Isfahan University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Isfahan University of Medical Sciences Leila Azadbakht, Phd</name>
      <address>
        <city>Isfahan</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 25, 2013</lastchanged_date>
  <firstreceived_date>June 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isfahan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Leila Azadbakht</investigator_full_name>
    <investigator_title>Isfahan University of Medical Sciences</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tangier Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
